Document is current
Any future updates will be listed below
-
Authors
Obr, Ales
Malarikova, Diana
Kriegova, Eva
Urbankova, Helena
Zemanova, Zuzana
Manakova, Jirina
Petrackova, Anna
Vatolikova, Michaela
Berkova, Adela
Forsterova, Kristina
Furst, Tomas
Hruskova, Andrea
Flodr, Patrik
Hanackova, Veronika
Prochazka, Vit
Papajik, Tomas
Trneny, Marek
Klener, Pavel
-
Funding
Funding for this research was provided by:
Ministry of Health of the Czech Republic (MH CZ – DRO (FNOl, 00098892), MH CZ – DRO (FNOl, 00098892), MH CZ – DRO (FNOl, 00098892), MH CZ-DRO-VFN-64165, JG_2024_035, JG_2024_035, MH CZ – DRO (FNOl, 00098892), MH CZ-DRO-VFN-64165, MH CZ – DRO (FNOl, 00098892), MH CZ – DRO (FNOl, 00098892), MH CZ – DRO (FNOl, 00098892))
Internal grant agency (IGA_LF_2025_005, IGA_LF_2025_005, IGA_LF_2025_005, IGA_LF_2025_005, IGA_LF_2025_005, IGA_LF_2025_005, IGA_LF_2025_005)
the European Union – Next Generation EU (EXCELES, ID Project No. LX22NPO5102, EXCELES, ID Project No. LX22NPO5102)
The Leukemia & Lymphoma Society (MCL 7005-24)
Czech Science Foundation (GA23-05377S)
- License Information
-
More Information
Article History
Received: 26 June 2025
Accepted: 11 September 2025
First Online: 29 September 2025
Declarations
:
: The study was approved by respective institutional review boards; all patients gave informed written consent and were treated according to the Declaration of Helsinki.
: All authors consented to publication of the manuscript.
: The authors declare no competing interests.
